Enforcement Report - Week of June 7, 2023
Enforcement Report - Week of November 21, 2018
Enforcement Report - Week of September 12, 2018
Breckenridge Pharm Generic Megestrol Acetate Receives Approval In US
Hi-Tech Pharmacal Generic Megestrol Acetate Receives Approval In US
I am delighted that we have expanded our successful partnership with PharmaSwiss and provide patients and physicians with additional treatment options that address unmet medical needs in each specific therapeutic category”, said Alan Raffensperger, senior vice president and Chief Operating Officer at Sobi.
TWi Pharmaceuticals, Inc. today announced that it launched its generic version of Par Pharmaceutical's MEGACE ES® (megestrol acetate oral suspension) 625mg/5ml after the United States District Court for the District of Maryland reinstated its finding that United States Patent No. 7,101,576 (the '576 Patent) is invalid.
12 cancer drugs may come under price control